Margaret G Mcglynn Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Margaret G Mcglynn is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 178 shares of VRTX, which is worth approximately $86,506. The most recent transaction as insider was on May 01, 2022, when has been sold 921 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 178

0% 3M change

0% 12M change

Total Value Held $86,506

MARGARET G MCGLYNN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 01 2022	SELL Sale (or disposition) back to the issuer	-	921 Reduced 83.8%	178 Common Stock
Apr 08 2022	SELL Open market or private sale	$1,404,200 $280.84 p/Share	5,000 Reduced 81.98%	1,099 Common Stock
Apr 08 2022	BUY Exercise of conversion of derivative security	$637,700 $127.54 p/Share	5,000 Added 45.05%	6,099 Common Stock
Mar 31 2022	SELL Open market or private sale	$1,311,050 $262.21 p/Share	5,000 Reduced 81.98%	1,099 Common Stock
Mar 31 2022	BUY Exercise of conversion of derivative security	$637,700 $127.54 p/Share	5,000 Added 45.05%	6,099 Common Stock
Jan 28 2022	SELL Open market or private sale	$1,210,500 $242.1 p/Share	5,000 Reduced 81.98%	1,099 Common Stock
Jan 28 2022	BUY Exercise of conversion of derivative security	$637,700 $127.54 p/Share	5,000 Added 45.05%	6,099 Common Stock

Jun 01 2021	SELL Sale (or disposition) back to the issuer	-	699 Reduced 38.88%	1,099 Common Stock
May 01 2021	BUY Grant, award, or other acquisition	-	921 Added 33.87%	1,798 Common Stock

Also insider at

APD

Air Products & Chemicals, Inc. Basic Materials

Director

NVAX

NOVAVAX INC Healthcare

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

MGM